Abvc Biopharma ABVC
NASDAQ ABVC
$1.02 -0.04 (-3.77%)
At close: Oct 1, 2026 · 4:00 PM EDT

Abvc Biopharma (ABVC) Non Operating Interest Expenses (2010 - 2026)

Updated

Abvc Biopharma (ABVC) reported Non Operating Interest Expenses of $42,323 for Q2 2026, down 67.3% from $129,413 a year earlier and down 14.3% from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Abvc Biopharma's Non Operating Interest Expenses came in at $155,210, down 80.3% year-over-year; for FY2025, it came in at $415,890, down 49.6% from FY2024.

  • Non Operating Interest Expenses has a five-year compound annual growth rate of 0.5% (FY2020 to FY2025).
  • By year, Non Operating Interest Expenses came in at $825,899 in FY2024 (-37.1%), $1.31 million in FY2023 (+346.9%), $293,968 in FY2022 (+29.4%) and $227,210 in FY2021 (-43.9%).
  • Five-year quarterly Non Operating Interest Expenses spans a low of -$76,368 in Q4 2023 and a high of $1.22 million in Q3 2023.
  • Year over year, Non Operating Interest Expenses has now declined in each of the last five quarters, with an average decline of 59.0% over the last seven quarters.
  • The high point for year-over-year Non Operating Interest Expenses in five years was Q3 2023 (growth of 863.1%); the low point was Q1 2022 (a decline of 86.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $49,377 (Q1 2026), $32,551 (Q4 2025) and $30,959 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Abvc Biopharma 27.31 Mn 29.30 Mn - 42,323.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 42,323.00
Mar 31, 2026 49,377.00
Dec 31, 2025 32,551.00
Sep 30, 2025 30,959.00
Jun 30, 2025 129,413.00
Mar 31, 2025 222,967.00
Dec 31, 2024 216,715.00
Sep 30, 2024 220,429.00
Jun 30, 2024 207,079.00
Mar 31, 2024 181,676.00
Dec 31, 2023 -76,368.00
Sep 30, 2023 1.22 Mn
Jun 30, 2023 114,752.00
Mar 31, 2023 56,663.00
Dec 31, 2022 134,461.00
Sep 30, 2022 126,536.00
Jun 30, 2022 14,758.00
Mar 31, 2022 18,213.00
Dec 31, 2021 -24,367.00
Sep 30, 2021 38,677.00
API Access

Abvc Biopharma Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ABVC&period=max&api_key=YOUR_API_KEY